XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.7.0.1

INVESTMENTS (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2017
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Investments in Unconsolidated Affiliates | The Company's investments in unconsolidated affiliates consisted of the following (in thousands):
| Carrying Value |  | Equity in Net Income (Loss)
|  |  |  | Three Months Ended March 31, | Nine Months Ended March 31,
| March 31, 2017 | June 30, 2016 |  | 2017 | 2016 | 2017 | 2016
FFF Enterprises, Inc. | $ | 91,469 |  | $ | — |  |  | $ | 217 |  | $ | — |  | $ | 4,394 |  | $ | — |
BloodSolutions, LLC | 2,091 |  | 2,185 |  |  | (42 | ) | — |  | (94 | ) | — |
PharmaPoint, LLC | 4,318 |  | 4,572 |  |  | (92 | ) | (108 | ) | (254 | ) | (284 | )
Innovatix, LLC | — |  | 9,043 |  |  | — |  | 6,735 |  | 10,743 |  | 15,992 |
Other investments | 1,000 |  | 1,000 |  |  | — |  | — |  | — |  | 294 |
Total investments | $ | 98,878 |  | $ | 16,800 |  |  | $ | 83 |  | $ | 6,627 |  | $ | 14,789 |  | $ | 16,002 |
Schedule of Marketable Securities, Classified as Available-For-Sale | At June 30, 2016, marketable securities, classified as available-for-sale, consisted of the following (in thousands):
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Market Value
June 30, 2016 |  |  |  |
Corporate debt securities | $ | 33,267 |  | $ | — |  | $ | (135 | ) | $ | 33,132 |
Asset-backed securities | 14,755 |  | 3 |  | (1 | ) | 14,757 |
Total marketable securities | $ | 48,022 |  | $ | 3 |  | $ | (136 | ) | $ | 47,889 |

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration